Why the study?
Autoimmune myocarditis associated with autoimmune diseases can cause CAVB, but related autoantigens and underlying mechanisms are unclear, and cases with positive anti-SSA/Ro antibodies are rare.
In adults with anti-SSA/Ro antibody-positive autoimmune myocarditis and complete atrioventricular block, immunosuppressive therapy may improve hemodynamics and clear antibodies, but permanent pacemaker implantation may still be required for irreversible conduction system damage.
Answers are grounded in this paper and cite their sources.
Immunosuppression may improve hemodynamics in anti-SSA/Ro myocarditis; leaves open whether it prevents pacemaker need for irreversible conduction damage.
BACKGROUND: Autoimmune myocarditis (AM) associated with autoimmune diseases can cause complete atrioventricular block (CAVB), but the related autoantigens and the underlying mechanisms are unclear. Anti-SSA/Ro antibodies may play an important role in this process, but cases of AM with positive anti-SSA/Ro antibodies are rare. In addition, arrhythmias, such as atrioventricular block, are very common in patients with autoimmune diseases, but severe atrioventricular block requiring permanent pacemaker implantation is extremely rare. CASE SUMMARY: The patient in this case had AM with anti-SSA/Ro antibody positivity, which was associated with connective tissue disease, and the patient subsequently developed CAVB. After intensive immunosuppressive therapy, the antibody test results became negative, and pulmonary hypertension significantly improved. However, the outcome of permanent pacemaker implantation did not change. CONCLUSION: In clinical practice, the awareness of adult AM associated with autoimmune diseases combined with CAVB should be strengthened in clinicians, and anti-SSA/Ro antibodies may play a role in this process. Therefore, improving the detection of antibodies and early intervention, such as active immunosuppression therapy, may be very important for improving disease prognosis. For patients who do not respond to immunosuppressive therapy, implantation of a permanent pacemaker may become an essential treatment option.
No takes yet. Share an insight, caveat, or question.
Xi-Rui Yang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: